Paragon Wealth Strategies, LLC Abb Vie Inc. Transaction History

Paragon Wealth Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $6,915 - $8,293	-50 Reduced 13.09%	332 $53,000
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $51,268 - $58,801	382 New	382 $51,000
Q3 2021 Oct 29, 2021	SELL	$106.4 - $120.78 $6,809 - $7,729	-64 Closed	0 $0
Q2 2021 Jul 12, 2021	BUY	$105.21 - $117.21 $6,733 - $7,501	64 New	64 $7,000

4,134

1.29B

17M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Paragon Wealth Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Paragon Wealth Strategies, LLC with notifications on news.